Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.25 MB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
The glycosylation pattern (sialylation, antennarity, presence of truncated/incomplete
structures, and the type of peripheral substitutions of glycans) of a recombinant glycoprotein
therapeutic protein can affect its immunogenicity, bioactivity pharmacokinetic profile, stability
and solubility. The main focus of the present work was to identify and to structurally
characterize unknown structural components of N-linked oligosaccharides attached to
recombinantly expressed therapeutic glycoproteins that can serve as reference standards for
monitoring and quantification of these structures in human biopharmaceuticals from CHO
cells or other expression systems. The N-linked oligosaccharide structures were isolated
from a CHO cell culture supernatant obtained from a GMP-compatible production process for
recombinant human erythropoietin. The total protein from the cell culture supernatant was
digested with trypsin and the glycopeptides were isolated by reversed phase
chromatography (RP-HPLC). The N-glycans were enzymatically released from glycopeptides
using polypeptide N-glycosidase F and were separated from the peptides by RP-HPLC. In a
first step N-linked oligosaccharides were fractionated according to their charge using a
MonoQ anion exchange chromatography column. In a second step fractions from the Mono
Q chromatography were further subfractionated by antennarity applying an aminopropyl
bonded phase matrix. Throughout all fractionation steps N-glycans pools were analyzed by
high pH anion exchange chromatography with pulsed amperometric detection (HPAECPAD).
Mass spectrometric analysis was applied for analysis of total N-glycans in the cell
culture supernatant and was also used for the structural elucidation of the newly detected Nglycans.
Three unusual N-linked oligosaccharides representing about 10 % of the total
carbohydrate material were identified and were characterized. Two of the glycan structures
were identified as phosphorylated oligomannosidic structures (Man5GlcNAc2 and
Man6GlcNAc2). A third structure was identified as being a monosialylated and
phosphorylated hybrid-type glycan with a proximal 1-6 linked Fuc. None of the unusual
oligosaccharides herein described had previously been reported in the literature. The three
N-glycan structures were recovered with purities above 95% and in sufficient quantities to be
used in the future as oligosaccharide reference standards in release tests for human
glycoprotein biopharmaceuticals produced in biotechnological production processes involving
CHO cell lines.
Description
Tese mest. , Engenharia Biológica, 2008, Universidade do Algarve
Keywords
Teses Engenharia biológica